Cargando…
Ambra1 modulates the sensitivity of breast cancer cells to epirubicin by regulating autophagy via ATG12
The sensitivity of breast cancer cells to epirubicin (EPI) is closely related to the efficacy of the drug and the prognosis of patients. A growing body of research has suggested that autophagy is involved in the treatment of a variety of cancers, including breast cancer, and modifies the sensitivity...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172055/ https://www.ncbi.nlm.nih.gov/pubmed/30027574 http://dx.doi.org/10.1111/cas.13743 |